(Q36628908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

Lucilla Parnetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Paolo Calabresi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Massimiliano Di Filippo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

974-983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Long-term synaptic depression in the striatum: physiological and pharmacological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cognitive function in Parkinson's disease: From description to theory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Visuospatial impairment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

The architecture of cognitive control in the human prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Frontal-subcortical circuits and human behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Neurotransmitters and neuromodulators in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Choline transporters, cholinergic transmission and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Acetylcholine-mediated modulation of striatal function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Striatal interneurones: chemical, physiological and morphological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine, learning and motivation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Anatomy of the dopamine system in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine receptors: from structure to behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Local infusion of scopolamine into intraparietal cortex slows covert orienting in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic-dependent cognitive deficits in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

A subcortico-cortical cholinergic system is affected in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic dysfunction in diseases with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Presynaptic nicotinic receptors modulating dopamine release in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Smoking, nicotine and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Cholinergic markers in degenerative parkinsonism: autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Disturbed frontal regulation of attention in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Lesions of the Basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine D1-like receptor activation excites rat striatal large aspiny neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Unilateral dopamine denervation blocks corticostriatal LTP

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine modulates release from corticostriatal terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Medial prefrontal and subcortical mechanisms underlying the acquisition of motor and cognitive action sequences in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Building neural representations of habits.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Dissociable roles of ventral and dorsal striatum in instrumental conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

The role of the medial frontal cortex in cognitive control

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

An area specialized for spatial working memory in human frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Selective D2 receptor actions on the functional circuitry of working memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

By carrot or by stick: cognitive reinforcement learning in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Mechanisms of cognitive set flexibility in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Neural bases of set-shifting deficits in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Pergolide effect on cognitive functions in early-mild Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

Excitatory effects of serotonin on rat striatal cholinergic interneurones

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970600-7

7 January 2021

10.1016/S1474-4422(06)70600-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17052664%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference